UVA Today

Q&A: What new drug is the FDA reviewing to treat Parkinson’s disease?

If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

New Hormone-Free Menopause Pill Cuts Hot Flashes by 55% and Improves Sleep

The Food and Drug Administration (FDA) just approved a brand-new, once-a-day pill to help treat hot flashes without the use ...

FDA Issues Recall on Popular Raw Dog Food Over Salmonella Risk

This recall comes amid growing concerns about the safety of raw pet food, as Salmonella contamination poses serious health ...

Major cholesterol drug recalled over ‘failed dissolution’: What patients must know

Your prescription may be involved. The FDA explains why suddenly stopping your medication is more harmful than taking it.
Backyard Garden Lover on MSN

One in Four Adults May Use Glp-1 Drugs This Year, Upending the Food Industry

At this month’s Food and Nutrition Conference and Expo in Nashville, one buzzword dominated conversations – GLP-1 medications ...

Over 140,000 bottles of popular cholesterol drug recalled

FDA announces Atorvastatin recall affecting over 140,000 bottles of cholesterol medication due to failed dissolution specs ...

Recall Roundup: Pet food, makeup wipes, Ford vehicles lead the list

Foodynamics and Raw Bistro Pet Fare are recalling several products due to possible contamination. Salmonella can affect ...

A liver transplant might save him — if he can get the drug he needs to stay alive long enough

A health insurance dispute is preventing a North Carolina man from getting a cancer drug his doctors say is necessary.

Will people be able to tell a difference eating food without artificial dyes?

The FDA is phasing out the use of eight artificial dyes by the end of 2026. Will people be able to tell the difference?
The Manila Times

Cellectar Biosciences Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for Iopofosine I 131 in Relapsed or Refractory Pediatric High-Grade Glioma

CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma Patients Showed Extended Progression Free Survival and Overall Survival ...